Director Flanagan James Francis Puts $109K into Cyabra Private Placement
CYAB is trading near its 52-week low of $0.306 (9.2% above the low) on light trading volume (0.4× avg).
Summary
Director Flanagan James Francis invested $109,193 in Cyabra's private placement, acquiring shares and warrants alongside the CEO. The insider buy underscores board confidence amid a going-concern warning and delisting risk.
Key Events · Ownership and Investor Activity · CYAB
-
Director Invests $109K in Private Placement
Director Flanagan James Francis purchased 114,940 common shares at $0.435 and 229,880 warrants (114,940 Series A at $0.50, 114,940 Series B at $0.45) for a total of $109,193 in Cyabra's $6M private placement.
-
Insider Commitment Amid Distress
The purchase follows CEO Dan Brahmy's $74,305 investment in the same placement, with both insiders backing the company despite a going-concern warning and Nasdaq delisting notice.
-
Warrant Terms and Potential Dilution
Series A warrants are exercisable at $0.50 for five years; Series B warrants at $0.45 for one year, both pending stockholder approval. If exercised, they would add 229,880 shares, representing significant potential dilution for a micro-cap company.
-
Post-Transaction Ownership
Flanagan now directly holds 344,820 shares (including 114,940 from the grant and 229,880 from warrant exercise potential), aligning his interests with shareholders.
Analysis · CYAB · Technology
Director Flanagan James Francis has purchased $109,193 in common stock and warrants in Cyabra's recent $6M private placement, joining CEO Dan Brahmy in backing the company. The investment includes 114,940 shares at $0.435 and warrants for 229,880 shares at $0.45–$0.50. This insider commitment arrives as Cyabra confronts a going-concern warning and a Nasdaq delisting threat, signaling board-level confidence in the company's survival despite severe financial distress.
At the time of this filing, CYAB was trading at $0.33 on NASDAQ in the Technology sector, with a market capitalization of approximately $4.7M. The 52-week trading range was $0.31 to $14.91. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.